DIVIGEL: payments to doctors
Payments that named DIVIGEL as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $137K
- Providers
- 4,121
- Transactions
- 6,519
- Average per transaction
- $21
The per-transaction average — $21 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 4,121 providers the average total is $33, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Vertical Pharmaceuticals, LLC | $83,748 | 61.2% |
| Avion Pharmaceuticals | $48,863 | 35.7% |
| Acella Pharmaceuticals, LLC | $4,035 | 3.0% |
| Osmotica Pharmaceutical Corp. | $124 | 0.1% |